source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[cell line]	characteristics[developmental stage]	characteristics[disease]	characteristics[ancestry category]	characteristics[sex]	characteristics[age]	characteristics[Individual]	characteristics[treatment]	characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	Factor Value[treatment]
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 10	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R1.raw	1	1	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 13	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R1.raw	1	2	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 16	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R1.raw	1	3	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 19	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R1.raw	1	4	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 22	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R1.raw	1	5	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 25	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R1.raw	1	6	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 28	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R1.raw	1	7	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 31	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R1.raw	1	8	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 34	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R1.raw	1	9	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 1	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R1.raw	1	10	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 4	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R1.raw	1	11	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 7	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R1.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R1.raw	1	12	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 11	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R2.raw	2	1	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 14	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R2.raw	2	2	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 17	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R2.raw	2	3	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 20	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R2.raw	2	4	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 23	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R2.raw	2	5	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 26	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R2.raw	2	6	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 29	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R2.raw	2	7	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 32	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R2.raw	2	8	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 35	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R2.raw	2	9	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 2	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R2.raw	2	10	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 5	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R2.raw	2	11	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 8	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R2.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R2.raw	2	12	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 12	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC1_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC1_R3.raw	3	1	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 15	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC2_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC2_R3.raw	3	2	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 18	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC3_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC3_R3.raw	3	3	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 21	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC4_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC4_R3.raw	3	4	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 24	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC5_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC5_R3.raw	3	5	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 27	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC6_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC6_R3.raw	3	6	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 30	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC7_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC7_R3.raw	3	7	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 33	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC8_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC8_R3.raw	3	8	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 36	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC9_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC9_R3.raw	3	9	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 3	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC10_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC10_R3.raw	3	10	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 6	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC11_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC11_R3.raw	3	11	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 1	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	1	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT126	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 2	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	2	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT127	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 3	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	control	3	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT128	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	control
PXD023423-Sample 4	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	1	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT129	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 5	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	2	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT130	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated
PXD023423-Sample 6	Homo sapiens	Wall of stomach	gastric cancer cells	not applicable	not available	Gastric adenocarcinoma	not available	not available	not available	not available	STO-609-treated	3	cell	run 9	proteomic profiling by mass spectrometry	CAMKK2_TP_bRPLC12_R3.raw	ftp://ftp.pride.ebi.ac.uk/pride-archive/2021/04/PXD023423/CAMKK2_TP_bRPLC12_R3.raw	3	12	TMT131	NT=Orbitrap Fusion;AC=MS:1002416	NT=Acetyl;AC=UNIMOD:1;PP=Protein N-term;MT=variable	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=TMT6plex;PP=Any N-term;MT=Variable;AC=UNIMOD:737	NT=TMT6plex;TA=K;MT=Variable;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	not available	34% NCE	10 ppm	0.05 Da	STO-609-treated